Trial NCT03684694

View at ClinicalTrials.gov 
Org. Study IDs: ADCT-402-103
Secondary IDs: 2018-002625-38

Last trial update was posted on 2024-02-06

MeSH Interventions

Ibrutinib Loncastuximab tesirine

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse Lymphoma, Mantle-Cell

Other Conditions

Diffuse Large B-Cell Lymphoma Mantle Cell Lymphoma

Stopping Reasons

Administrative decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID